Home
News
Create
Screeners
Insights
Prism Medico & Pharmacy
18.
47
-0.53
(-2.79%)
Market Cap
₹11.18 Cr
PE Ratio
19.00
Industry
Financial Services
Buy
Sell
Company Performance:
1D
-2.79%
1M
-3.50%
6M
+38.46%
1Y
+12.21%
5Y
-33.92%
View Company Insights
Latest news about Prism Medico & Pharmacy
Prism Medico and Pharmacy Limited Schedules Board Meeting for February 13, 2026 to Consider Q3FY26 Financial Results
3 hrs ago
Yesterday
Prism Medico and Pharmacy Limited has scheduled a board meeting for February 13, 2026, at 01:00 P.M. at its registered office in Himachal Pradesh to consider and approve Q3FY26 unaudited standalone financial results for the quarter ended December 31, 2025. The meeting agenda includes reviewing financial results with Limited Review Report as per SEBI Regulation 33 and discussing routine business matters. The company has notified both BSE (scrip code: 512217) and MSEI (symbol: PRISMMEI) in compliance with regulatory requirements.
Prism Medico and Pharmacy Limited Submits SEBI Depositories Compliance Certificate for Q3FY26
Jan 14, 2026
Prism Medico Reports Q2 Loss Amid Revenue Decline, Corrects Financial Statement Filing
Nov 21, 2025
Prism Medico & Pharmacy Limited Reports Remarkable Q1 Performance with ₹65.73 Lakh Net Profit
Sep 12, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation